EP2: AR-targeted therapies for advanced prostate cancer
October 14th 2021
Julie N. Graff, MD, of OHSU Knight Cancer Institute, comments on the impact of the availability of newer-generation androgen receptor inhibitors on treatment outcomes for patients with advanced prostate cancer.